Defiance Nasdaq Junior Biotechnology ETF IBBJ
29.87 USD +29.87
Day range unavailable
52-week range unavailable
News
etf.com ETF Odds & Ends: Closures Accelerate Plus, a large number of name and index changes occurred during the past two weeks.
etf.com ETF Odds & Ends: Launches Resurge Plus, expense ratio changes and other ETF developments occurred during the week.
etftrends.com Biotech ETFs Benefit From Moderna Dual Booster Shot News As the stock market attempts to reverse the recent pullback this month, Moderna shares climbed higher on Thursday after the company announced that it's creating a dual-purpose vaccine booster shot…
zacks.com Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News The FDA granted full approval of a COVID-19 vaccine made by Pfizer (PFE) and BioNTech that could accelerate inoculations in the United States.
etftrends.com Bet on Biotech Small Caps to Bounce Back Large cap biotechnology have strengthened in recent months, but smaller counterparts are still waiting on their 2021 moment. When that happens, the Defiance Nasdaq Junior Biotechnology ETF (IBBJ)…
investorplace.com 7 Stocks to Buy Now if You're Feeling Greedy While Others Are Fearful Stock markets run on fear and greed in the short term. Here are seven stocks to buy that look like they have significant long-term upside.
seekingalpha.com Biotech Innovations Remain At Forefront The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively…
seekingalpha.com Moving Beyond COVID In Biopharma Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April…
seekingalpha.com Defiance ETFs: A Revolution In Thematic ETF Investing (Podcast Transcript) Defiance ETFs: A Revolution In Thematic ETF Investing (Podcast Transcript)
etftrends.com Why Small Cap Biotech ETFs Are Still Brilliant Bets Small cap stocks are retreating. So are biotechnology names.
seekingalpha.com Defiance ETFs: A Revolution In Thematic ETF Investing (Podcast) Defiance ETFs: A Revolution In Thematic ETF Investing (Podcast)
etftrends.com Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021 After a lull in mergers and acquisitions activity, Big Pharma could begin to use its cash stores to buy out smaller targets, potentially fueling the momentum in biotechnology-related exchange traded…
marketwatch.com Biotech ETFs surge on vaccine rollout, Alexion-AstraZeneca tie-up Biotech exchange-traded funds rallied Monday as the rollout of the coronavirus vaccine across America shed a bullish light on the industry. The First Trust NYSE Arca Biotechnology Index Fund jumped…
benzinga.com New Biotech ETF Quick To Strut Its Stuff There are recipes for success for new exchange-traded funds. In an effort to attract assets and investors' attention, rookie ETFs can undercut established rivals on fees, offer exposure to a…
etftrends.com Young But Hungry: A New Defiance ETF is Defying Expectations The Defiance Nasdaq Junior Biotechnology ETF (IBBJ) is just a few months in, but it's already asserting itself in the biotechnology exchange traded funds arena, one teeming with competition. IBBJ…
businesswire.com IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index NEW YORK--(BUSINESS WIRE)---- $IBBJ #Biotech--About Defiance: Founded in 2018, Defiance ETFs is an exchange-traded funds (ETFs) sponsor and registered investment advisor, focused on thematic…
benzinga.com Defiance NextGen SPAC IPO ETF Launches: What Investors Need To Know An ETF based on special purpose acquisition companies that trades on a U.S. exchange is now available to investors for the first time.